Company intelligence / Profile preview

Plano Pharmaceuticals

Ownership
Private
Development stage
Other
01

Overview

Plano Pharmaceuticals develops and markets generic injectable therapeutics for the North American market, aiming to increase access to affordable, high-quality medications. No clinical trial data reported as they focus on approved generics.

Therapeutic areas
Other
Modalities
Small molecule (generic injectables)
Industry
Biotech
02

Drug pipeline

4 assets

PP003

Preclinical

3 more assets in the full pipeline.

Beyond the preview

Go deeper on Plano Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Plano Pharmaceuticals.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call